日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell fixed RNA profiling uncovers SEMA4D and LMCD1 as therapeutic targets in a liver fibrosis model

单细胞固定RNA谱分析揭示SEMA4D和LMCD1是肝纤维化模型中的治疗靶点

Duc, Pham Minh; Thuy, Le Thi Thanh; Hai, Hoang; Van Bao, Tran; Ha, Nguyen Thi; Anh, Pham Tuan; Ikenaga, Hiroko; Fujii, Hideki; Yoshida, Kanako; Enomoto, Masaru; Uchida-Kobayashi, Sawako; Yuasa, Hideto; Matsubara, Tsutomu; Huyen, Vu Thuong; Cheng, Yi; Yamagishi, Ryota; Ohtani, Naoko; Oikawa, Daisuke; Tokunaga, Fuminori; Kisseleva, Tatiana; Brenner, David A; Iwakiri, Yasuko; Gracia-Sancho, Jordi; Kawada, Norifumi

12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy

12-羟基十七碳三烯酸可预测核苷(酸)类似物治疗期间肝细胞癌的发生

Ikenaga, Hiroko; Kozuka, Ritsuzo; Inoue, Kirara; Matsubara, Tsutomu; Odagiri, Naoshi; Yoshida, Kanako; Kotani, Kohei; Kawamura, Etsushi; Hagihara, Atsushi; Fujii, Hideki; Enomoto, Masaru; Uchida-Kobayashi, Sawako

The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma.

过氧化物酶 3 对人类胰腺导管腺癌的分子检测、诊断和预后的影响

Kakehashi Anna, Suzuki Shugo, Nishidoi Yusaku, Hagihara Atsushi, Ikenaga Hiroko, Shiota Masayuki, Qiu Guiyu, Noura Ikue, Kuwae Yuko, Vachiraarunwong Arpamas, Fujioka Masaki, Gi Min, Kawada Norifumi, Wanibuchi Hideki

Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment

PPAR配体和纳米颗粒技术在代谢性脂肪性肝炎治疗中的应用

Vu, Hung Thai; Nguyen, Vien Duc; Ikenaga, Hiroko; Matsubara, Tsutomu